Members of the Division of Pediatric Endocrinology and Diabetology actively participate in numerous clinical and basic research studies, and division members successfully compete for both governmental and non-governmental research funding. The division participates in several national diabetes research consortiums, including Type 1 Diabetes TrialNet, DirecNet, the Type 1 Diabetes Exchange, and the Immune Tolerance Network.
Current clinical research interests include treatment of central precocious puberty, long-term outcomes of central precocious puberty, osteogenesis imperfecta, bone disease in children with cystic fibrosis, hypophosphatasia, congenital hypothyroidism, insulin pump usage in children with type 1 diabetes, endothelial progenitor cells in type 1 diabetes, continuous glucose monitoring in type 1 diabetes, immunomodulatory therapies to prevent or modify type 1 diabetes, quality of life in type 1 diabetes, long-term outcomes of growth hormone treatment, new agents for treatment of growth hormone deficiency, treatment of growth hormone deficiency, treatment of type 2 diabetes, and the relationship of sleep apnea to insulin resistance and obesity.